1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector
|
|
|
- Aubrie Farmer
- 5 years ago
- Views:
Transcription
1 1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 ) 5. By Sector Pediatric Vaccines Market and Forecast (2005 ) 5.1 Worldwide Pediatric Combinations & Boosters Vaccines Market 5.2 Worldwide Pediatric Enhanced Combinations Vaccines Market 5.3 Worldwide Pediatric Proprietary Vaccines Market 6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast 6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 ) Number of Measles, Mumps & Rubella Cases () Number of Measles, Mumps & Rubella (MMR) Vaccines Doses Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines Market Size of Measles, Mumps & Rubella (MMR) Vaccines 6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 ) Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases () Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines Market Size of Haemophilus Influenzae Type B (HIB) Vaccines 6.3 Polio Vaccines and Forecast (2005 ) Number of Polio Cases () Number of Polio Vaccines Doses Immunization Coverage of Polio Vaccines Market Size of Polio Vaccines 6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 ) Number of Diphtheria, Tetanus & Pertussis (DTP) Cases () Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines 6.5 Pneumococcal Vaccines and Forecast (2005 ) Number of Pneumococcal Cases (2000) Number of Pneumococcal Vaccines Doses Immunization Coverage of Pneumococcal Vaccines Market Size of Pneumococcal Vaccines 6.6 Rotavirus Vaccine and Forecast (2006 ) Number of Rotavirus Cases (2008 & 2009) Number of Rotavirus Vaccines Doses Immunization Coverage of Rotavirus Vaccines Market Size of Rotavirus Vaccine 6.7 Hepatitis Pediatric Vaccines and Forecast (2005 ) Number of Hepatitis Pediatric Vaccines Doses Immunization Coverage of Hepatitis Pediatric Vaccines Market Size of Hepatitis Pediatric Vaccines 6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 ) Number of Varicella/Chicken Pox Vaccines Doses Market Size of Varicella/Chicken Pox Vaccines
2 6.9 Other Pediatric Vaccines and Forecast (2005 ) Market Size of Other Pediatric Vaccines 7. Growth Drivers of Pediatric Vaccines Market 7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be Done Rotavirus Vaccine Introduction Financial Challenges Cost Effective Future Steps Conclusion 7.2 GAVI Model Increases Vaccine Manufacturers The Partnership Model The Business Model 7.3 WHO Global Vaccine Action Plan ( ) 8. Challenges of Pediatric Vaccine Market 8.1 Roadblocks in Expanding Access to Newer Pediatric Vaccines 8.2 Impediment in Pediatric Vaccine Research & Development 8.3 Barriers to New Entrants in the Pediatric Vaccines Market List of Figures Figure 2 1: Worldwide Pediatric Vaccines Market (Million US$), 2006 Figure 2 2: Worldwide Forecast for Pediatric Vaccines Market (Million US$), 2012 Figure 3 1: Worldwide (Sector wise) Pediatric Vaccines Market Share (Percent), 2005 Figure 3 2: Worldwide (Sector wise) Forecast for Pediatric Vaccines Market Share (Percent), 2012 Figure 5 1: Worldwide Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 Figure 5 2: Worldwide Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$), 2012 Figure 5 3: Worldwide Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 Figure 5 4: Worldwide Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$), 2012 Figure 5 5: Worldwide Pediatric Proprietary Vaccines Market (Million US$), 2005 Figure 5 6: Worldwide Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 Figure 6 1: Worldwide Number of MMR Vaccines Doses (Million Doses), 2005 Figure 6 2: Worldwide Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 Figure 6 3: Worldwide Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 Figure 6 4: Worldwide Forecast for Immunization Coverage of MMR Vaccines Doses
3 Figure 6 5: Worldwide Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 Figure 6 6: Worldwide Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 Figure 6 7: Worldwide Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income Countries, Figure 6 8: Worldwide Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 Figure 6 9: Worldwide Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines Figure 6 10: Worldwide Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 Figure 6 11: Worldwide Forecast for Immunization Coverage of Haemophilus Influenzae Type B Vaccines Figure 6 12: Worldwide Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 Figure 6 13: Worldwide Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2012 Figure 6 14: Worldwide Number of Doses of Polio Vaccines (Million Doses), 2005 Figure 6 15: Worldwide Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 Figure 6 16: Worldwide Immunization Coverage of Polio Vaccines (Million Doses), 2005 Figure 6 17: Worldwide Forecast for Immunization Coverage of Polio Vaccines Figure 6 18: Worldwide Polio Vaccines Market (Million US$), 2005 Figure 6 19: Worldwide Forecast for Polio Vaccines Market (Million US$), 2012 Figure 6 20: Worldwide Number of Doses of DTP Vaccines (Million Doses), 2005 Figure 6 21: Worldwide Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 Figure 6 22: Worldwide Immunization Coverage of DTP Vaccines (Million Doses), 2005 Figure 6 23: Worldwide Forecast for Immunization Coverage of DTP Vaccines Figure 6 24: Worldwide Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005 Figure 6 25: Worldwide Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2012 Figure 6 26: Worldwide Pneumococcal Vaccine Pipeline, Figure 6 27: Worldwide Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 Figure 6 28: Worldwide Forecast for Number of Doses of Pneumococcal Vaccines
4 Figure 6 29: Worldwide Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 Figure 6 30: Worldwide Forecast for Immunization Coverage of Pneumococcal Vaccines Figure 6 31: Worldwide Pneumococcal Vaccines Market (Million US$), 2005 Figure 6 32: Worldwide Forecast for Pneumococcal Vaccines Market (Million US$), 2012 Figure 6 33: Worldwide Number of Doses of Rotavirus Vaccines (Million Doses), 2010 Figure 6 34: Worldwide Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 Figure 6 35: Worldwide Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 Figure 6 36: Worldwide Forecast for Immunization Coverage of Rotavirus Vaccines Figure 6 37: Worldwide Rotavirus Vaccine Market (Million US$), 2006 Figure 6 38: Worldwide Forecast for Rotavirus Vaccine Market (Million US$), 2012 Figure 6 39: Worldwide Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 Figure 6 40: Worldwide Forecast for Number of Doses of Hepatitis Pediatric Vaccines Figure 6 41: Worldwide Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 Figure 6 42: Worldwide Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines Figure 6 43: Worldwide Hepatitis B Vaccine Introduction in High & Low-income countries, Figure 6 44: Worldwide Hepatitis Pediatric Vaccines Market (Million US$), 2005 Figure 6 45: Worldwide Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 Figure 6 46: Worldwide Number of Doses of Varicella Vaccines (Million Doses), 2005 Figure 6 47: Worldwide Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 Figure 6 48: Worldwide Varicella Vaccines Market (Million US$), 2005 Figure 6 49: Worldwide Forecast for Varicella Vaccines Market (Million US$), 2012 Figure 6 50: Worldwide Other Pediatric Vaccines Market (Million US$), 2005 Figure 6 51: Worldwide Forecast for Other Pediatric Vaccines Market (Million US$),2012 Figure 7 1: Prices of Childhood Vaccines (US$), Figure 7 2: Reduction in Rotavirus Vaccine Prices (US$), May & April 2012 Figure 7 3: Increasing Number of GAVI Suppliers Based in Emerging Markets List of Tables
5 Table 4 1: Worldwide (Disease wise) Pediatric Vaccines Market Share (Percent), 2006 Table 4 2: Worldwide (Disease wise) Forecast for Pediatric Vaccines Market Share (Percent), 2012 Table 6 1: Worldwide (By Geographic Region) Number of Measles Cases (Number), Table 6 2: Worldwide (By Geographic Region) Number of Mumps Cases (Number), Table 6 3: Worldwide (By Geographic Region) Number of Rubella Cases (Number), Table 6 4: Worldwide (By Geographic Region) Number of Haemophilus Influenzae Type B Meningitis Cases (Number), Table 6 5: Worldwide (By Geographic Region) Number of Polio Cases (Number), 2001 Table 6 6: Worldwide (By Geographic Region) Number of Diphtheria Cases (Number), Table 6 7: Worldwide (By Geographic Region) Number of ntetanus Cases (Number), Table 6 8: Worldwide (By Geographic Region) Number of ttetanus Cases (Number), Table 6 9: Worldwide (By Geographic Region) Number of Pertusis Cases (Number), Table 6 10: Worldwide (By Geographic Region) Pneumococcal Cases & Death in Children Under 5 Years of Age (Number), 2000 Table 6 11: Worldwide (By Geographic Region) WHO Coordinated Rotavirus Surveillance (Number), Table 6 12: Worldwide (By Geographic Region) WHO Coordinated Rotavirus Surveillance Positive Cases (Number & Percent), 2009 Table 7 1: Worldwide Total Future Deaths Averted through Vaccination (Million), 2020 Table 7 2: Goal-Level Indicators, & 2020
Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines
Vaccine Innovation: Challenges and Opportunities to Protect Health Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines Protecting Health with Vaccines HEALTH IMPROVEMENT Population Impact Guidelines
Healthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
APPENDIX EE VACCINE STATUS AND DATE
VACCINE STATUS AND DATE Vaccine Status, Date is a ten-character field which presents information about each of the vaccines required for children. For most cases, the first character tells the vaccine
Communicable Disease & Immunization
Communicable Disease & Immunization Ingham County Health Surveillance Book 2016 Communicable Disease & Immunization - 1 Communicable Disease & Immunization T he control of communicable disease and immunization,
Schools. Kindergarten
1 of 5 7/29/2014 4:14 PM Schools North Carolina law requires all children in the state to receive certain immunizations. Records are checked when children enter school or child care. Kindergarten Vaccination
FLORIDA DEPARTMENT OF EDUCATION DOE INFORMATION DATA BASE REQUIREMENTS VOLUME I: AUTOMATED STUDENT INFORMATION SYSTEM AUTOMATED STUDENT DATA ELEMENTS
Vaccine Status, Date Definition/Domain Vaccine Status, Date is a ten-character field which presents information about each of the vaccines required for children. For most cases, the first character tells
Summary of Methods. Figure 1: Vaccines have been very effective in reducing most vaccine-preventable diseases in Colorado.
The Children s Hospital March 2004 Marsha Anderson, MD James Todd, MD Vaccine-preventable Diseases in Colorado s Children, 2002 For More Information: The Children s Hospital Public Affairs Department 303-861-8555
The Financial Sustainability of New Vaccine Introduction in the Poorest Countries :
The Financial Sustainability of New Vaccine Introduction in the Poorest Countries : Evidence from the First Phase of GAVI (Global Alliance for Vaccines and Immunization) Patrick Lydon lydonp@who.int Session:
Role of Partnerships in Developing Innovative Vaccines: Brazil
Role of Partnerships in Developing Innovative Vaccines: Brazil SAGE Meeting, October 2010 Reinaldo Guimarães, M.D, MSc. Secretary of Science, Technology and Strategic Inputs Ministry of Health of Brazil
Table Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines
Table Of Contents Executive Summary THE GLOBAL VACCINES INDUSTRY Scope and Methodology Overview Pediatric Preventative Vaccines THE MARKET Adult Preventative Vaccines THE MARKET TOTAL MARKET ISSUES AND
Proof of residency in East Orange is mandatory (see Residency Requirements)
Pre-K Registration Requirements Child must be at least 3 or 4 years old by October 1st of the current school year Immunization (shot records) are mandatory Age appropriate vaccinations for children entering
Public Health Wales Vaccine Preventable Disease Programme
Public Health Wales Vaccine Preventable Disease Programme LHB practice level reports Cwm Taf LHB July June August Page of Contents. Purpose and Background.... LHB Summary.... Practice level data Merthyr
CHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES
CHAPTER ONE: EXECUTIVE SUMMARY The Global Vaccine Industry o Scope and Methodology o Overview o Pediatric Preventative Vaccines o The Market o Adult Preventative Vaccines o The Market o Total Market o
Appendix An Assessment Tool to Determine the Validity of Vaccine Doses
Appendix 4.4 - An Assessment Tool to Determine the Validity of Vaccine Doses Note: Refer to the Canadian Immunization Guide and New Brunswick (NB) immunization program directives for recommendations for
Economic aspects of viral hepatitis in Turkey. Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009
Economic aspects of viral hepatitis in Turkey Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009 Vaccines currently recommended for children in National Immunization
2016/17 Vaccination and Immunisation list of additional services and enhanced services
2016/17 Vaccination and Immunisation list of additional services and enhanced services 2016/17 Vaccination and Immunisation list of additional services and enhanced services Version number: 1 First published:
The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007
History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we
2017/18 Immunisation programmes list of additional and enhanced services
2017/18 Immunisation programmes list of additional and enhanced services 2017/18 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2017 Prepared
2018/19 Immunisation programmes list of additional and enhanced services
2018/19 Immunisation programmes list of additional and enhanced services 2018/19 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2018 Prepared
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing
Global Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
Utah s Immunization Rule Individual Vaccine Requirements
Utah s Immunization Rule Individual Vaccine Requirements Which vaccines are required for school entry in Utah? Grades K-6: 5 doses DTaP (4 doses if the 4 th dose was given after the 4 th birthday) 4 doses
Walter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate Director, Emory Vaccine Center
Could Vaccines be a Possible Model For Pediatric Drug Development? June 13, 2006 Walter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate
Dear Parents. To obtain your child s immunisation history you can:
Dear Parents The Public Health Act require schools and child care centres to keep information about students immunisation records with respect to diphtheria, pertussis (whooping cough), polio, haemophilus
Cyprus Experience. Dr. Elena Papamichael Ministry of Health
Cyprus Experience Dr. Elena Papamichael Ministry of Health Cyprus became independent on1960. On 1974, Turkish troops invaded in the island disturbing the willing for peaceful living. Since then, Turkey
2016 Vaccine Preventable Disease Summary
2016 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared October 2017 2016 Summary of Vaccine Preventable Diseases (VPDs) Reported to Ottawa County
PATH Quick Reference Guide: Coding for Pediatric Health HEDIS Measures
PATH Quick Reference Guide: Coding for Pediatric Health HEDIS Measures This guide is designed to be a quick reference tool to help with medical coding of select Healthcare Effectiveness Data and Information
Centers for Disease Control and Prevention. Final Revised Vaccine Information Materials for MMR
This document is scheduled to be published in the Federal Register on 03/15/2018 and available online at https://federalregister.gov/d/2018-05299, and on FDsys.gov BILLING CODE: 4163-18-P DEPARTMENT OF
Pertussis. (Whole-cell pertussis vaccines) must not be frozen, but stored at 2 8 C. All wp vaccines have an expiry date of months.
Program Management 61_5 The wp vaccines have a considerably lower price than ap vaccines and, where resources are limited and the vaccine is well accepted by the local population, wp vaccine remains the
Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation
Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation Background Information Immunisation services in Syria Syria had good immunisation services,
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids Contents Introduction Nunavut Recommended Childhood Immunization Schedule Nunavut Routine Adult Immunization Schedule Nunavut Immunization
2015 Vaccine Preventable Disease Summary
2015 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared April 2016 2015 Summary of Vaccine Preventable Diseases (VPD) Reported to Ottawa County
Age-Specific Mortality Rate for All Infectious Diseases, Both Male & Female, Years
Per 100,000 population Health Indicators 10. Infectious Diseases 10-01. Infectious Disease Mortality Description Mortality Rate for all Infectious Diseases, by Age Group 400 Age-Specific Mortality Rate
Immunize children and adults against vaccine-preventable disease in
PHD/CHSB & SH CHSB: Yvette Wright x1274, Teresa Moberly x1242 SHB: Helen Nace x1655, Jennifer Toma x8156 Program Purpose Program Information Immunize children and adults against vaccine-preventable disease
Preventive Health FOR YOU AND YOUR FAMILY
Preventive Health FOR YOU AND YOUR FAMILY Patient Information Preventive Health Care Welcome to Iowa Health Physicians. Now that you have chosen a healthcare provider it is time to schedule an appointment
Recommended Health Screenings
Recommended Health Screenings UnitedHealthcare appreciates the preventive care you deliver to our members. Please use the below health screening chart to schedule screenings based on the member s age and
Establishing a second-year-of-life (2YL) healthy child visit
Establishing a second-year-of-life (2YL) healthy child visit Dr Rudi Eggers Presentation to the Global Vaccines and Immunization Research Forum Sandton, 15 March 2016 Session Objectives Provide an overview
Adolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
VACCINE FACT BOOK 2012
VACCINE FACT BOOK 2012 Preface Prevention is better than cure is a proverb in many other languages as well. This idea is central to the development of vaccines, which have transformed human health since
kernfamilyhealthcare.com. Si necesita esta información en español, por favor llámenos.
Together in... p revention Preventive Care Gu id e Kern Family Health Care wants you to get good health care. These preventive care guidelines help you stay healthy by preventing diseases or by finding
Centers for Disease Control and Prevention. Proposed Revised Vaccine Information Materials for MMR
This document is scheduled to be published in the Federal Register on 10/18/2016 and available online at https://federalregister.gov/d/2016-25144, and on FDsys.gov BILLING CODE: 4163-18-P DEPARTMENT OF
Vaccine Finance. Overview of stakeholder input and NVAC working group draft white paper. Walt Orenstein, MD
Vaccine Finance Overview of stakeholder input and NVAC working group draft white paper Walt Orenstein, MD Consultant to the National Vaccine Program Office July 24, 2008 Number of Vaccines in the Routine
Preventive care is important at every age. Making good health choices now can boost your health and well-being for a lifetime.
Adult Recommendations Preventive care is important at every age. Making good health choices now can boost your health and well-being for a lifetime. Asthma and COPD Well-Child Visits Children s Immunization
BODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES
BODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES Topic 3 This topic links in with MICROBES (from unit 1) 1. What are the 3 types of microbes? 2. Which microbe do antibiotics destroy? 3. What microbe
Vaccines and other immunological antimicrobial therapy 1
Vaccines and other immunological antimicrobial therapy 1 Vaccines Vaccine: a biological preparation that provides active acquired immunity to a particular disease. Vaccine typically contains an agent that
Deployment of Combination Vaccines and STI vaccines
Deployment of Combination Vaccines and STI vaccines Advancing Prevention Technologies for Sexual and Reproductive Health Symposium Berkeley, Ca March 24, 2009 Eileen Yamada, MD, MPH California Department
Up-to-date immunization coverage rates among 2-year olds in Saskatchewan First Nations communities
Up-to-date immunization coverage rates among 2-year olds in Saskatchewan First Nations communities Presented by: Michelle Allard-Johnson BScN, RN Regional Immunization Coordinator First Nations Inuit Health
'Contagious Comments' Department of Epidemiology
'Contagious Comments' Department of Epidemiology Vaccine-Preventable Diseases in Colorado s Children, 27 Sean O Leary MD, Elaine Lowery JD MSPH, Carl Armon MSPH, James Todd MD Vaccines have been highly
WHY WE RE HERE. Melinda Wharton, MD, MPH Director, Immunization Services Division. National Center for Immunization & Respiratory Diseases
National Center for Immunization & Respiratory Diseases WHY WE RE HERE Melinda Wharton, MD, MPH Director, Immunization Services Division AIM Leadership Conference February 8, 2017 Vaccines save lives.
National Vaccine Plan: From Strategy to Implementation
National Vaccine Plan: From Strategy to Implementation July 26, 2011 Sarah Landry Senior Advisor, National Vaccine Program Office Office of the Assistant Secretary for Health Department of Health and Human
A. Children born in 1942 B. Children born in 1982 C. Children born in 2000 D. Children born in 2010
Who do you think received the most immunologic components in vaccines? Development of which vaccine slowed after the invention of antibiotics? A. Children born in 1942 B. Children born in 1982 C. Children
Immunizations are among the most cost effective and widely used public health interventions.
Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean
RECOMMENDED IMMUNIZATIONS
Recommended Immunization Schedule for Persons Aged 0 Through 6 Years United States 2010 1 2 4 6 12 15 18 19 23 2 3 4 6 Vaccine Age Birth month months months months months months months months years years
Current National Immunisation Schedule Dr Brenda Corcoran National Immunisation Office.
Current National Immunisation Schedule 2012 Dr Brenda Corcoran National Immunisation Office Objectives To outline immunisation schedules in Ireland Primary childhood schedule Vaccine uptake rates School
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)
2017 Vaccine Preventable Disease Summary
2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed
Manitoba Health, Healthy Living and Seniors
Manitoba Health, Healthy Living and Seniors Manitoba Annual Immunization Surveillance Report, 2012 and 2013 January 1, 2012 to December 31, 2013 with 5-year average comparison (January 1, 2007 to December
Legal Aspects of Children s Health Services A Guide to Public Health Services for Children. Part 4: Immunizations
Legal Aspects of Children s Health Services A Guide to Public Health Services for Children Part 4: Immunizations Developed in 2014 by in partnership with www.nwcphp.org Updated June 24, 2014 Authors: Jane
Immunizations for Children and Teens with Suppressed Immune Systems
Immunizations for Children and Teens with Suppressed Immune Systems Your child is starting treatment that will suppress the immune system. This will affect how your child s body responds to routine immunizations
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines 1 Vaccines: the single most effective medical intervention 2 Vaccines save lives Millions of cases
Immunization Coverage & Vaccine Preventable Diseases in northern BC 2013
Immunization Coverage & Vaccine Preventable Diseases in northern BC 213 Revised April, 214 Immunizations are some of the best health investments that we can make. Along with better sanitation and clean
Line Diagnosis 2017 Codes 2018 Codes. 3 Tuberculosis A15- through A19- A15- through A19-, O98.01-
Table 6A Code Changes Table 6A: Selected Diagnoses and Services Rendered * Indicates change from 2017 1-2. Selected Infectious and Parasitic Diseases Symptomatic / Asymptomatic HIV B20, B97.35, O98.7-,
A Publication for Local Health Departments & TVFC Providers serving Health Service Regions 2 & 3. Texas Immunization Rates most Improved in Nation
THE SHARPSHOOTER April 2009 A Publication for Local Health Departments & TVFC Providers serving Health Service Regions 2 & 3 Texas Immunization Rates most Improved in Nation During the 43 rd National Immunization
VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine
VACCINES TRIUMPHS AND TRIBULATIONS William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine Never in the history of human progress has a better and cheaper
Essential Vaccinations for HIV-Positive Adults and Adolescents
Essential Vaccinations for HIV-Positive Adults and Adolescents Janak A. Patel, MD Professor & Director, Pediatric Infectious Diseases Director, Maternal-Child Program University of Texas Medical Branch
Vaccine-Preventable Diseases in Colorado s Children 2009 Sean O Leary MD, Carl Armon PhD, Joni Reynolds, RNC, MSN, James Todd MD
State of the Health of Colorado s Children Vaccine-Preventable Diseases in Colorado s Children 29 Sean O Leary MD, Carl Armon PhD, Joni Reynolds, RNC, MSN, James Todd MD Vaccines have been highly effective
THURGOOD MARSHALL ACADEMY PCHS ATHLETIC INFORMATION PACKET SY
THURGOOD MARSHALL ACADEMY PCHS ATHLETIC INFORMATION PACKET SY 2015-2016 THE INFORMATION CONTAINED IN THIS PACKET MUST BECOMPLETED BY BOTH THE STUDENT ATHLETE AND PARENT/GUARDIAN AND RETURNED TO MRS. THOMPSON,
Family and Travel Vaccinations
Family and Travel Vaccinations We offer the full range of baby, child and family vaccinations. We are able to tailor schedules to your child s needs or international schedule. We have a suggested vaccination
ECONOMICS OF THE VACCINE MARKET: SIZE, GROWTH AND REVENUES
ECONOMICS OF THE VACCINE MARKET: SIZE, GROWTH AND REVENUES 1 Relationship between research funding and burden of disease Source: Global Forum for Health Research Monitoring Financial Flows for Health Research
Guidelines Description USPSTF HRSA CDC Benefit Description Types Ages
Guidelines Description USPSTF Evidence-based items or services that have a rating of A or B in the current recommendations of the United States Preventive Services Task Force HRSA Evidence-informed exams,
ANNUAL HEALTH SCREENINGS AND IMMUNIZATIONS GUIDE MEN WOMEN ALL ADULTS CHILDREN
AND IMMUNIZATIONS GUIDE MEN WOMEN ALL ADULTS CHILDREN MEN PROSTATE CANCER Testicular exam Age 18+ PSA test Ages 50-75, based on risk WOMEN BREAST CANCER Self breast exam Monthly Clinical breast exam Annually
Vaccine Preventable Diseases
Olmsted County, Minnesota Community Health Improvement Plan 2018 2020 Vaccine Preventable Diseases Data Profile Making the Healthy Choice the Easy Choice A Collaborative Community Effort Led by: Olmsted
Annotated Bibliography:
Annotated Bibliography: Montana Code Annotated 2009. Montana Legislative Services. September 10, 2010 http://data.opi.mt.gov/bills/mca/20/5/20-5-403.htm. A school may not allow a student to attend unless
VACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
Update on Transition: the case of Honduras. Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016
Update on Transition: the case of Honduras Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016 GAVI Support for Honduras Content Honduras EPI Situation 2011-2016 Vaccination
Early Learning Centre Immunisation Policy Legislation ACT Public Health Regulations (2000)
Early Learning Centre Immunisation Policy Legislation ACT Public Health Regulations (2000) National Quality Standard / Education and Care Services National Regulations Standard 2.1 Each child s health
What DO the childhood immunization footnotes reveal? Questions and answers
What DO the childhood immunization footnotes reveal? Questions and answers Stanley E. Grogg, DO, FACOP, FAAP he Advisory Committee on Immunization Practices (ACIP) recommends the childhood vaccination
Managing cost considerations and access to technology for cost effective vaccine manufacture in developing countries.
Managing cost considerations and access to technology for cost effective vaccine manufacture in developing countries. Amol R. Dindokar Serum Institute of India ltd. Overview Disease Control Priorities
Public Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.
ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.
Selected vaccine introduction status into routine immunization
Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF
School Nurse Regional Update School Year Immunizations COLORADO IMMUNIZATION BRANCH
School Nurse Regional Update 2017-18 School Year Immunizations COLORADO IMMUNIZATION BRANCH Talking Points Child Care Immunizations K through 12 th Grade Immunizations Official Medical and Non-Medical
Overall presentation of IVR Strategy
Annex 3 Overall presentation of IVR Strategy Presentation to the IVR Advisory committee (IVAC) April 2007 Outline Why does WHO invest in Research & Development? What is the Initiative for Vaccine Research
Vaccines for Children
Vaccines for Children 12 24 old Our goal is to offer your family the best care possible, which includes making sure your child is up to date on all vaccines. DTaP (Diptheria, Tetanus, Pertussis) Vaccine
I. In accordance with Virginia Code relative to enrollment of certain children in public schools:
Immunization Requirements I. In accordance with Virginia Code relative to enrollment of certain children in public schools: A. Children not properly immunized in accordance with the Virginia Department
Access to vaccination in GAVI countries and at global level
Access to vaccination in GAVI countries and at global level Stefano Malvolti Director, Vaccine Implementation GAVI Alliance 15th ADVANCED COURSE OF VACCINOLOGY May 12, 2014 Global progress to MDG 4 for
Vaccination and Immunity
Vaccination and Immunity Eric A. Utt, PhD Director, Worldwide Science Policy Pfizer Inc California Immunization Coalition Summit 2012 Completing the Circle: Ensuring Adult & Adolescent Vaccination for
Vaccines. Global impact of a preventive technology. Edwin J. Asturias, MD
Vaccines Global impact of a preventive technology Edwin J. Asturias, MD Associate Professor of Pediatrics and Epidemiology Director for Latin America Center for Global Health, Colorado School of Public
Preventive Care ALASKA NATIVE HEALTH STATUS REPORT 13
Preventive Care ALASKA NATIVE HEALTH STATUS REPORT 13 14 ALASKA NATIVE HEALTH STATUS REPORT Highlights Approximately half (56.5%) of Alaska Native adults received dental care in the past year. Approximately
AKE WITH Y KEEP AND T
VACCINATION RECORD Vaccination, the best protection This booklet is an important document. It is the only record of all the vaccines you have received. You will need it all your life, so keep it in a safe
Global Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
2016 Cross-Cutting Measure Set
1 0059 Diabetes: Hemoglobin A1c Poor Control: Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the 46 0097 Claims, Registry Medication Reconciliation Post Discharge:
OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE
OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE Dr Tiong Wei Wei, MD, MPH Senior Assistant Director Policy and Control Branch, Communicable Diseases Division Ministry of Health 9
Immunization Records. childrens.memorialhermann.org CARE /13
Immunization Records childrens.memorialhermann.org 713.222.CARE 4400209-4/13 Personal Health Record of The Woodlands Contact Information Date and time of birth Place of birth Pediatrician name, phone number
The Danish childhood vaccination program SUMMARY IN ENGLISH
The Danish childhood vaccination program SUMMARY IN ENGLISH 2018 Why do we vaccinate children in Denmark? Childhood immunization programs are some of the most effective preventive public health measures
Quest for Quality: Immunizations
Quest for Quality: Immunizations DANE COUNTY IMMUNIZATION COALITION MEMBERSHIP MEETING November 13, 2012 Elaine Rosenblatt MSN, FNP-BC Director, Quality and Care Management UW Medical Foundation/ Unity
The schedule for childhood vaccination is:(web link to NHS Childhood Immunisation Schedule for 2008
Immunisations and vaccinations Immunisation is an effective public health intervention for promoting good health and protecting individuals and populations against serious disease and infection through
Recommended Childhood Immunization Schedu...ates, January - December 2000, NP Central
Recommended Childhood Immunization Schedule United States, January - December 2000 Vaccines 1 are listed under routinely recommended ages. Solid-colored bars indicate range of recommended ages for immunization.
THE KEATS GROUP PRACTICE REGISTRATION FORM PLEASE COMPLETE IN BLOCK CAPITALS PERSONAL BACKGROUND INFORMATION
Registration checked by: Date: 11 & Under THE KEATS GROUP PRACTICE REGISTRATION FORM PLEASE COMPLETE IN BLOCK CAPITALS PERSONAL BACKGROUND INFORMATION Male Female Has your child ever been treated at this